MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update

Go back to MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
Mannkind Corporation (NASDAQ: MNKD) Delayed: 4.17 +0.11 (2.71%)
Previous Close $4.06    52 Week High $2.51 
Open $4.00    52 Week Low $0.41 
Day High $4.32    P/E N/A 
Day Low $4.00    EPS $-0.64 
Volume 3,205,639       

Mannkind Corporation (NASDAQ: MNKD) Delayed: 4.17 +0.11 (2.71%)
Previous Close $4.06    52 Week High $2.51 
Open $4.00    52 Week Low $0.41 
Day High $4.32    P/E N/A 
Day Low $4.00    EPS $-0.64 
Volume 3,205,639